Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
  • Buchan Group: Responsible Research and Innovation

    We are focusing on how to make research and innovation relevant to society, sustainable and fair for everyone.

  • Barker Group: Centre for Advancement of Sustainable Medical Innovation (CASMI)

    We aim to address the issues that have led to current failures in the translation of basic bioscience into affordable and widely adopted new treatments.

  • Ogg Group: Cutaneous Immunology Group

    The aim of the group is to understand, at the molecular and cellular level, the role of human cutaneous immune responses in mechanisms of disease, treatment and vaccination. As well as contributing to an understanding of disease pathogenesis, we aim to translate our findings to changes in clinical practice.

  • Drakesmith Group: Iron and Immunity

    We are investigating how iron and anaemia influence immunity and infectious diseases. Our research inspires treatments that control iron physiology to benefit the host at the expense of pathogens.

  • Buchan Group: Laboratory of Cerebral Ischemia

    The Laboratory of Cerebral Ischemia is a pre-clinical research group aiming to discover both the mechanisms which underlie cell death in stroke and to develop novel strategies to reduce this.

  • Cerundolo Group

    We focus on gaining a better understanding of the mechanisms that control the cell-cell interplay required for optimal expansion and activation of tumour-specific T cell populations and to apply this knowledge to the development of better treatment strategies in cancer patients.

  • Eggeling Group

    We apply and optimize advanced optical microscopy techniques, such as super-resolution STED microscopy, to decipher molecular dynamics in an unprecedented way. Our main focus is molecular plasma membrane organization, especially following immune responses.

  • Dong Group: Human Anti-Viral & -Cancer T cell responses

    The group's main objective is in determining factors which affect T cells in the control of viral infection and in the development of cancer. In addition, we work on the anti-viral restriction factor IFITM3 to establish the mechanism of action of this important protein.

  • Davis Group: T-cell Biology Group

    We are interested in how lymphocytes decide to mount immune responses against, for example, tumours. This involves trying to understanding how leukocyte receptors, such as the T-cell receptor and immune checkpoints, are triggered.

  • Newbold Group: Molecular Parasitology

    Our group's interests centre on the role of multi-gene families in malaria in pathogenesis, immune evasion and their evolution.